A liver-targeting Cu(l) chelator relocates Cu in hepatocytes and promotes Cu excretion in a murine model of Wilson's disease - BIG - Biologie à Grande Échelle (BGE)
Article Dans Une Revue Metallomics Année : 2020

A liver-targeting Cu(l) chelator relocates Cu in hepatocytes and promotes Cu excretion in a murine model of Wilson's disease

Khémary Um
  • Fonction : Auteur

Résumé

Copper chelation is the most commonly used therapeutic strategy nowadays to treat Wilson's disease, a genetic disorder primarily inducing a pathological accumulation of Cu in the liver. The mechanism of action of Chel2, a liver-targeting Cu(i) chelator known to promote intracellular Cu chelation, was studied in hepatic cells that reconstitute polarized epithelia with functional bile canaliculi, reminiscent of the excretion pathway in the liver. The interplay between Chel2 and Cu localization in these cells was demonstrated through confocal microscopy using a fluorescent derivative and nano X-ray fluorescence. The Cu(i) bound chelator was found in vesicles potentially excreted in the canaliculi. Moreover, injection of Chel2 either intravenously or subcutaneously to a murine model of Wilson's disease increased excretion of Cu in the faeces, confirmingin vivobiliary excretion. Therefore, Chel2 turns out to be a possible means to collect and excrete hepatic Cu in the faeces, hence restoring the physiological pathway.
Fichier principal
Vignette du fichier
Monestier_Metallomics_2020.pdf (1.31 Mo) Télécharger le fichier
Origine Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-02911050 , version 1 (20-12-2021)

Identifiants

Citer

Marie Monestier, Anais M. Pujol, Aline Lamboux, Martine Cuillel, Isabelle Pignot-Paintrand, et al.. A liver-targeting Cu(l) chelator relocates Cu in hepatocytes and promotes Cu excretion in a murine model of Wilson's disease. Metallomics, 2020, 12 (6), pp.1000-1008. ⟨10.1039/d0mt00069h⟩. ⟨hal-02911050⟩
175 Consultations
75 Téléchargements

Altmetric

Partager

More